Manufacture at Sypharma

Emphasizing efficiency, our production and manufacturing processes consistently deliver high-quality outcomes, ensuring cost-effectiveness alongside flexible capacity and scalability.

Our Agile
Facility

GMP Compliant Manufacturing

Sypharma operates state-of-the-art Good Manufacturing Practice (cGMP) facilities compliant with multiple regulatory standards.

Our licenses encompass TGA (Therapeutic Goods Administration) for medicines and medical devices, and APVMA (Australian Pesticide and Veterinary Medicines Authority) accreditation.

Single Use Manufacturing

Efficiency, Flexibility and Quality

  • Reduced Contamination Risk: minimize the risk of cross-contamination between batches, ensuring product purity and safety.
  • Increased Flexibility: allows for greater flexibility in manufacturing processes, facilitating rapid changeovers between different products or formulations.
  • Cost Savings: eliminating the need for cleaning and sterilization of traditional equipment reduces operational costs associated with labor, utilities, and downtime.
  • Scalability: easier scaling of production capacity, allowing companies to adjust manufacturing volumes more efficiently in response to market demand.
  • Faster Time to Market: simplified setup and validation processes, accelerating the development and production of pharmaceutical products, reducing time to market.

Single Use
Manufacturing

Efficiency, Flexibility and Quality

Advanced single-use manufacturing solutions for clinical trial injectables, ensuring flexible, efficient, and contamination-free GMP production

Reduced Contamination Risk

Minimize the risk of cross-contamination between batches, ensuring product purity and safety.

Increased Flexibility

Allows for greater flexibility in manufacturing processes, facilitating rapid changeovers between different products or formulations.

Cost Savings

Eliminating the need for cleaning and sterilization of traditional equipment reduces operational costs associated with labor, utilities, and downtime.

Scalability

Easier scaling of production capacity, allowing companies to adjust manufacturing volumes more efficiently in response to market demand.

Faster Time to Market

Simplified setup and validation processes, accelerating the development and production of pharmaceutical products, reducing time to market.

Intravenous Fluid
Manufacturing

Automation, Optimization and Digitalization

  • Precision and Accuracy: ensured precise measurement and mixing of IV solutions, reducing the risk of errors in formulation.
  • Consistency: guaranteed uniformity in product quality and composition, enhancing patient safety and treatment efficacy.
  • Increased Efficiency: reduced manual intervention and streamlines production workflows, leading to higher output rates and faster turnaround times.
  • Cost Reduction: minimized labor requirements and optimized resource utilization, with lower operational costs.

Intravenous Fluid Manufacture

Automation, Optimization and Digitalization

Specialising in the GMP manufacture of intravenous fluids for clinical and commercial use, delivering precision, sterility, and quality at scale.

Precision and Accuracy

Ensured precise measurement and mixing of IV solutions, reducing the risk of errors in formulation.

Consistency

Guaranteed uniformity in product quality and composition, enhancing patient safety and treatment efficacy.

Increased Efficiency

Reduced manual intervention and streamlines production workflows, leading to higher output rates and faster turnaround times.

Cost Reduction

Minimized labor requirements and optimized resource utilization, with lower operational costs.

Non-sterile
Manufacture

Customization, Adaption and Solution

  • Customer Consultation: The manufacturing process begins with a thorough consultation with the customer to understand their needs, preferences, and specifications for the desired liquid product.
  • Formulation Development: Based on the customer’s requirements, formulation experts develop a customized recipe or formulation for the liquid product.
  • Prototype Production: Once the formulation is developed, prototypes of the liquid product are produced for testing and evaluation.
  • Scale-Up and Production: Once the formulation has been finalized and approved by the customer, it is scaled up for commercial production.
  • Quality Assurance: Throughout the manufacturing process, rigorous quality assurance measures are implemented to ensure the integrity, purity, and safety of the liquid product.

Non-sterile
Manufacture

Customization, Adaption and Solution

Sypharma manufactures GMP-grade excipients to support pharmaceutical and biopharmaceutical formulation with consistent quality and regulatory compliance.

Customer Consultation

The manufacturing process begins with a thorough consultation with the customer to understand their needs, preferences, and specifications for the desired liquid product.

Formulation Development

Based on the customer’s requirements, formulation experts develop a customized recipe or formulation for the liquid product.

Prototype Production

Once the formulation is developed, prototypes of the liquid product are produced for testing and evaluation.

Scale-Up and Production

Once the formulation has been finalized and approved by the customer, it is scaled up for commercial production.

Quality Assurance

Throughout the manufacturing process, rigorous quality assurance measures are implemented to ensure the integrity, purity, and safety of the liquid product.

In-house
Quality Control

Accuracy, Compliance and Reliability

In-house Chemistry & Microbiology laboratories enhances our ability to maintain stringent quality standards, support product development initiatives, ensure regulatory compliance, and ultimately deliver high-quality pharmaceutical products to our customers.

Rapid Testing and Analysis

Allowing for quick testing and analysis of raw materials, in-process samples, and finished products.

Quality Control Assurance

Implementing robust quality control measures throughout the manufacturing process.

Enhanced Product Development

Evaluating new formulations, assess product stability, and optimize manufacturing processes, leading to the continuous improvement of your product offerings.

Cost Efficiency

Minimizing the need for outsourcing these services to third-party laboratories, resulting in cost savings and greater control over expenses.

Our dedication to quality is uncompromising.

And it covers every stage of everything we do. From development, clinical testing, and production through to commercialisation. Hundreds of organisations around the world trust Sypharma to fast track drug development through every stage of research, development, quality, safety and commercialisation.

Unlocking resources

Collaboration & Potential

We work together with innovative biotech developers to your drug production destination means the world to us, and our dedicated team of experts will support and guide you from the earliest stage of development through to commercialization.


  • Clinical Development of SpikoGen®

    An Advax-CpG55.2 adjuvanted recombinant spike protein vaccine.

    Read Fact Sheet
  • Ensuring Efficacy and Safety

    The Critical Role of Pharmaceutical Cold Chain Transportation

    Read Fact Sheet
  • University of Queensland partners with Sypharma

    Sypharma partners with The University of Queensland for the manufacture of their CoVID-19 Vaccine Product.

    Read Press Release
  • Technovalia, Sypharma and BioNet announce the establishment of Genetis

    Technovalia, Sypharma and BioNet announce the establishment of Genetis, the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA and recombinant vaccines.

    Read Press Release

Since 2005 unlocking healthier futures.